Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say

WASHINGTON, July 27 (Reuters) - The U.S. Justice Department has opened a criminal investigation into Cassava Sciences Inc (SAVA.O) involving whether the biotech company manipulated research results for its experimental Alzheimer's drug, two people familiar with the inquiry said.